Abstract:AIMS:Although programmed cell death protein 1 (PD-1) typically serves as a target for immunotherapies, a few recent studies have found that PD-1 is expressed in the nervous system and that neuronal PD-1 might play a crucial role in regulating neuronal excitability. However, whether brain-localized PD-1 is involved in seizures and epileptogenesis is still unknown and worthy of in-depth exploration.METHODS:The existence of PD-1 in human neurons was confirmed by immunohistochemistry, and PD-1 expression levels were measured by real-time quantitative PCR (RT-qPCR) and western blotting. Chemoconvulsants, pentylenetetrazol (PTZ) and cyclothiazide (CTZ), were applied for the establishment of in vivo (rodents) and in vitro (primary hippocampal neurons) models of seizure, respectively. SHR-1210 (a PD-1 monoclonal antibody) and sodium stibogluconate (SSG, a validated inhibitor of SH2-containing protein tyrosine phosphatase-1 [SHP-1]) were administrated to investigate the impact of PD-1 pathway blockade on epileptic behaviors of rodents and epileptiform discharges of neurons. A miRNA strategy was applied to determine the impact of PD-1 knockdown on neuronal excitability. The electrical activities and sodium channel function of neurons were determined by whole-cell patch-clamp recordings. The interaction between PD-1 and α-6 subunit of human voltage-gated sodium channel (Nav1.6) was validated by performing co-immunostaining and co-immunoprecipitation (co-IP) experiments.RESULTS:Our results reveal that PD-1 protein and mRNA levels were upregulated in lesion cores compared with perifocal tissues of surgically resected specimens from patients with intractable epilepsy. Furthermore, we show that anti-PD-1 treatment has anti-seizure effects both in vivo and in vitro. Then, we reveal that PD-1 blockade can alter the electrophysiological properties of sodium channels. Moreover, we reveal that PD-1 acts together with downstream SHP-1 to regulate sodium channel function and hence neuronal excitability. Further investigation suggests that there is a direct interaction between neuronal PD-1 and Nav1.6.CONCLUSION:Our study reveals that neuronal PD-1 plays an important role in epilepsy and that anti-PD-1 treatment protects against seizures by suppressing sodium channel function, identifying anti-PD-1 treatment as a novel therapeutic strategy for epilepsy.

The potential antiepileptogenic effect of neuronal Cx36 gap junction channel blockage

Effect of Connexin 36 Blockers on the Neuronal Cytoskeleton and Synaptic Plasticity in Kainic Acid-Kindled Rats

Inhibition Of Connexin 36 Decreases Seizure Activity In The Kainic Acid-Induced Rat Model Of Epilepsy

[The Relations Between Electrical Synapse and the Mechanism of Epilepsy in Genetical Epilepsy-Prone Rat].

A Purinergic P2 Receptor Family-Mediated Increase in Thrombospondin-1 Bolsters Synaptic Density and Epileptic Seizure Activity in the Amygdala-Kindling Rat Model

Targeting Gap Junction in Epilepsy: Perspectives and Challenges

Role of Gap Junctions in Epilepsy

Trpv1: A Potential Target for Antiepileptogenesis

Characterization of Connexin36-Expressing Neurons in Adult Rat Somatosensory Cortex

The role of gap junction inhibitors in the epileptic animal model induced by injection of kainic acid

An update for epilepsy research and antiepileptic drug development: Toward precise circuit therapy

Endothelial Cdk5 Deficit Leads to the Development of Spontaneous Epilepsy Through CXCL1/CXCR2-mediated Reactive Astrogliosis

Neuronal Protective Effect of Songling Xuemaikang Capsules Alone and in Combination with Carbamazepine on Epilepsy in Kainic Acid-Kindled Rats

Role Of Gap Junction Protein 36 In Pentetrazole-Induced Acute Epilepsy In Rats

Channel Block of the Astrocyte Network Connections Accounting for the Dynamical Transition of Epileptic Seizures

Connexin:a Potential Novel Target for Protecting the Central Nervous System?

Attenuation of Neuropathic Pain by Inhibiting Electrical Synapses in the Anterior Cingulate Cortex.

Anterior Cingulate epilepsy: mechanisms and modulation

The Neurovascular Unit Dysfunction in the Molecular Mechanisms of Epileptogenesis and Targeted Therapy

Anticonvulsant Activity of Halogen-Substituted Cinnamic Acid Derivatives and Their Effects on Glycosylation of PTZ-Induced Chronic Epilepsy in Mice.

Anti-PD-1 Treatment Protects Against Seizure by Suppressing Sodium Channel Function